Susanna Leskelä
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Microtubule and mitosis dynamics, 14-3-3 protein interactions, Lung Cancer Treatments and Mutations, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes(2010)265 cited
- → The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients(2010)207 cited
- → Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas(2010)207 cited
- → The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors(2009)163 cited
- → Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients(2009)131 cited
- → Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity(2010)127 cited
- → Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis(2009)127 cited
- → Molecular genetic heterogeneity in undifferentiated endometrial carcinomas(2016)102 cited
- → Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma(2019)81 cited
- → Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy(2013)79 cited